1Gaspar LE, Zamorano M,Shamsa F, et al. Permanent 125 Iodine implants for recurrent malignant gliomas[ J]. Int J Radiation Ontology Bio Phys, 1999,43(5) :977-982.
2Haligan JB, Stelzer KJ, Rostomily RC, et al. Operation and permanent low activity ^125 I brachytherapy for recurrent high-grade astrocytomas[J]. Int J Radiation Oncology Bio Phys, 1996,35(3) : 341-347.
7Older RA, Synder B, Krupski TL, et al. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy [ J ]. J Urol,2001, 165(5) :1 590-1 592.
8Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for nonsmall cell lung cancer: observed local control with implantation of Ⅰ- 125 brachytherapy seeds [ J ]. Ann Thorac Surg, 2003,75 ( 1 ) : 237 - 243.
9De Silva VF,Gutin PH,Deen DF,et al. Relative biological effectiveness of ^125Ⅰ sources in a murine brachytherapy model[J]. Int J Radiat Oncol Biol Phys, 1984,10 (11) :2 109 -2 111.
10Ling CC, Huang DY, Barnett C, et al. Improved dose distribution with customized Ⅰ- 125 source loading in temporary interstitial implants [ J ]. Int J Radiation Oncology Biol Phy, 1988,15 (3) : 769 - 774.
